Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-02-25 @ 4:58 PM
Study NCT ID:
NCT00653458
Status:
COMPLETED
Last Update Posted:
2008-04-11
First Post:
2008-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions
Sponsor:
Par Pharmaceutical, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-08
Start Date Type:
None
Primary Completion Date:
2002-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-04
First Submit QC Date:
None
Study First Post Date:
2008-04-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-04-10
Last Update Post Date:
2008-04-11
Last Update Post Date Type:
ESTIMATED